Glutathione S-transferase M1, T1 and P1 polymorphisms and bladder cancer risk in Egyptians

International Journal of Biological Markers

Volumn 20, Issue 1, 2005, Pages 69-72

  Saad, A A ^a,c   O'Connor, P J ^a   Mostafa, M H ^b   Metwalli, N E ^c   Cooper, D P ^a,d   Povey, Andrew C ^a,e   Margison, G P ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b ALEXANDRIA UNIVERSITY   (Egypt)

^c ALEXANDRIA UNIVERSITY   (Egypt)

^d MICROMASS UK LTD   (United Kingdom)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Bladder cancer; Glutathione S transferases; Polymorphism; Risk factors; Schistosomiasis

Indexed keywords

GENOMIC DNA; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; UNCLASSIFIED DRUG;

ADENOCARCINOMA; ADULT; AGE; AGED; ARTICLE; BLADDER BIOPSY; BLADDER CANCER; CANCER PATIENT; CANCER RISK; CHI SQUARE TEST; CONFIDENCE INTERVAL; CONTROLLED STUDY; CYSTECTOMY; EGYPT; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN POLYMORPHISM; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; TRANSITIONAL CELL CARCINOMA;

EID: 18744414832     PISSN: 03936155     EISSN: None     Source Type: Journal    
DOI: 10.5301/JBM.2008.829     Document Type: Article

References (21)

1. Kahan E, Ibrahim AS, El Najjar K, et al. Cancer patterns in the Middle East - special report from the Middle East Cancer Society. Acta Oncol 1997; 36: 631-6.
2. Bedwani R, el-Khwsky F, La Vecchia C, Boffetta P, Levi F. Descriptive epidemiology of bladder cancer in Egypt. Int J Cancer 1993; 55: 351-2.
3. Mady EA. Cytokeratins as serum markers in Egyptian bladder cancer. A comparison of CYFRA 21-1, TPA and TPS. Int J Biol Markers 2001; 16: 130-5.
4. Mostafa MH, Sheweita SA, O'Connor PJ. Relationship between schistosomiasis and bladder cancer. Clin Microbiol Rev 1999; 12: 97-111.
5. Bedwani R, el-Khwsky F, Renganathan F, et al. Epidemiology of bladder cancer in Alexandria, Egypt: tobacco smoking. Int J Cancer 1997; 73: 64-7.
6. Coles BF, Kadlubar FF. Detoxification of electrophilic compounds by glutathione S-transferase catalysis: determinants of individual response to chemical carcinogens and chemotherapeutic drugs?. Biofactors 2003; 17: 115-30.
7. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the enzyme to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol 1995; 30: 445-600.
8. Rebbeck TR. Molecular epidemiology of the human glutathione s-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prevent 1997; 6: 733-43.
9. Whalen R, Boyer TD. Human glutathione S-transferases. Semin Liver Dis 1998; 18: 345-58.
10. Hu X, Ji X, Srivastava SK, et al. Mechanism of differential catalytic efficiency of two polymorphic forms of human glutathione S-transferase P1-1 in the glutathione conjugation of carcinogenic diol epoxide of chrysene. Arch Biochem Biophys 1997; 345: 32-8.
11. Engel LS, Taioli E, Pfeiffer R, et al. Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: a HuGE review. Am J Epidemiol 2002; 156: 95-109.
12. Hung RJ, Boffetta P, Brennan P, et al. GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population. Int J Cancer 2004; 110: 598-604.
13. Kim WJ, Kim H, Kim CH, et al. GSTT1-null genotype is a protective factor against bladder cancer. Urology 2002; 60: 913-8.
14. Toruner GA, Akyerli C, Ucar A, et al. Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and bladder cancer susceptibility in the Turkish population. Arch Toxicol 2001; 75: 459-64.
15. Lafuente A, Zakahary MM, el Aziz MA, et al. Influence of smoking in the glutathione-S-transferase M1 deficiency-associated risk for squamous cell carcinoma of the bladder in schistosomiasis patients in Egypt. Br J Cancer 1996; 74: 836-8.
16. Anwar WA, Abdel Rahman SZ, El Zein RA, Mostafa HM, Au WW. Genetic polymorphism of GSTM1, CYP2E1 and CYP2D6 in Egyptian bladder cancer patients. Carcinogenesis 1996; 17: 1923-9.
17. Abdel Rahman SZ, Anwar WA, Abdel Aal WE, Mostafa HM, Au WW. GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer. Cancer Detect Prev 1998; 22: 129-38.
18. Lewis SJ, Cherry NM, McLNiven R, Barber PV, Povey AC. GSTM1, GSTT1 and GSTP1 polymorphisms and lung cancer risk. Cancer Lett 2002; 180: 165-71.
19. de Vries HG, Collee JM, van Veldhuizen MH, et al. Validation of the determination of deltaF5O8 mutations of the cystic fibrosis gene in over 11,000 mouthwashes. Hum Genet 1996; 97: 334-6.
20. Abdel Rahman SZ, el Zein RA, Anwar WA, Au WW. A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 genes in population studies. Cancer Lett 1996; 107: 229-33.
21. Smith MT, Evans CG, Doane Setzer P, Castro VM, Tahir MK, Mannervik B. Denitrosation of 1,3-bis(2-chloroethyl)-1-nitrosourea by class mu glutathione transferases and its role in cellular resistance in rat brain tumor cells. Cancer Res 1989; 49: 2621-5.